Idiopathic erythrocytosis in a patient on chronic hemodialysis.
10.1016/j.krcp.2014.09.004
- Author:
Dong Hyun LEE
1
;
Ji Hye MIN
;
Sang Byung BAE
;
Hyo Wook GIL
;
Jong Oh YANG
;
Eun Young LEE
;
Sae Yong HONG
Author Information
1. Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea. eylee@sch.ac.kr
- Publication Type:Case Report
- Keywords:
End-stage renal disease;
Erythrocytosis;
Hemodialysis
- MeSH:
Aged;
Anemia;
Bone Marrow;
Carboxyhemoglobin;
Erythropoietin;
Hematinics;
Humans;
Kidney Failure, Chronic;
Oxygen;
Polycythemia*;
Renal Dialysis*;
Urinary Bladder Neoplasms
- From:Kidney Research and Clinical Practice
2015;34(1):60-63
- CountryRepublic of Korea
- Language:English
-
Abstract:
A 78-year-old man on hemodialysis presented to our hospital with erythrocytosis. He had started hemodialysis 4 years previously, with a hemoglobin level of 9.8 g/dL, and was administered erythropoiesis stimulating agents and ferrous sulfate. Two years previously, his hemoglobin level increased to 14.5 g/dL and the treatment for anemia was discontinued. He continued hemodialysis thrice weekly; however, the hemoglobin level had increased to 17.0 g/dL at the time of presenting to our hospital. His serum erythropoietin level was 31.4 mIU/mL (range, 3.7-31.5 mIU/mL), carboxyhemoglobin level was 0.6% (range, 0-1.5%), and oxygen saturation in ambient air was 95.4%. The JAK2 V617F mutation was not observed and other bone marrow abnormalities were not identified. The patient was diagnosed with bladder cancer and a transurethral resection was performed. Eight months after the treatment of bladder cancer, his hemoglobin level was 15.1 g/dL, and he was diagnosed with idiopathic erythrocytosis.
